InMode to Participate at the 2021 ICR Conference
InMode Ltd. (Nasdaq: INMD) announced its participation in the 2021 ICR Conference held virtually from January 11-14, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode Ltd. (Nasdaq: INMD) announced its participation in the 2021 ICR Conference held virtually from January 11-14, 2021. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, Chief Medical Officer, will engage in a fireside chat on January 14, 2021, at 3:15 pm EST. A live webcast will be accessible to the public and archived for 90 days post-event. InMode specializes in innovative medical technologies utilizing radio-frequency (RF) technology, enhancing surgical procedures across multiple medical fields.
Details
News Market Reaction – INMD
The recorded move for INMD in the trading session of this news was -1.59%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM, Israel, Jan. 11, 2021 /PRNewswire/ -- /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced its participation in the 2021 ICR Conference, which is being held virtually January 11-14, 2021. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, M.D., Chief Medical Officer, will participate in a fireside chat on Thursday, January 14, 2021 at 3:15 pm EST.
A live webcast of the presentations will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 90 days following the live presentation.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
For more information about InMode, please visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654
View original content:http://www.prnewswire.com/news-releases/inmode-to-participate-at-the-2021-icr-conference-301203598.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.